Michael Wasserman
QuietNamed in filings at Prince StreetOn the current fund
- Board seats filed
- 6
Named in filings at Prince StreetOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Moximed | Medical devices | August 2024 | Advent Life Sciences, Lightstone Singapore, Lightstone Ventures, NEA |
| CLARIFY MEDICAL | Medical devices | May 2018 | 7wire Ventures, SV Life Sciences |
| Tiltify | Fintech | November 2017 | None on file |
| Vertiflex | Medical devices | March 2017 | None on file |
| Orbus Therapeutics | Biotech & pharma | August 2015 | Longitude 103.8 East, Longitude Capital, Longitude Prime, Venbio Select |
| NEUWAVE MEDICAL | Medical devices | September 2014 | Versant Venture Capital |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Michael Wasserman on the board, based on 6 filed seats with a verified or cited source.